الفهرس Only 14 pages are availabe for public view
 |  | from | 154 |  |  |
| | | from | 154 | | |
Abstract
Worldwide, lung cancer is the most commonly diagnosed cancer and causes more deaths than any other cancer [10,11] .It is the second most common malignancy after prostate cancer in men and breast cancer in women[12] . Its high mortality rate results from both a high incidence rate and a low survival rate, with only 14% of USA lung cancer patients surviving 5 years after diagnosis [13]. Lung cancer is also the leading cause of cancer death in most countries[14,16].Throughout all age groups, incidence of lung cancer rises sharply with age [14].
In Egypt lung cancer is the second most common cancer in men and second leading cause of death, after bladder cancer. Lung cancer cases accounts for 6.1% male, 12.3% female, male to female ratio 4.7%. Median age of lung cancer in males is 60years. The one year survival rate for lung cancer has increased from 34%in 1975 to 42% in 1998{3}.
This study is a retrospective descriptive study to identify the relative and different clinico-pathological aspects of lung cancer in the patients presented to Suez Canal University Hospital Center of Oncology and Nuclear Medicine (SCUCON) from January 1995 to December 2007 inclusive, and to study the response to different modalities of treatment adopted to lung cancer patients in SCUCON. The files of SCUCON were reviewed and data was processed.
Five thousands six hundred and fifty eight patients were presented to (SCUCON) in this period. Lung cancer was documented in 106 patients with a relative frequency incidence of 1,87% of the total cases.
The studied patients were in the age group ranging from less than twinty and more than sixty .The age-specific incidence rate shows that 59.4% of lung cancer patients were in the age group (60 years or more) while only 1.8% were in the age